A novel marker, ARM58, confers antimony resistance to Leishmania spp
- PMID: 24596667
- PMCID: PMC3940081
- DOI: 10.1016/j.ijpddr.2013.11.004
A novel marker, ARM58, confers antimony resistance to Leishmania spp
Abstract
Protozoa of the Leishmania genus cause a variety of disease forms that rank at the top of the list of neglected tropical diseases. Anti-leishmanial drugs based on pentavalent antimony have been the mainstay of therapy for over 60 years and resistance against them is increasingly encountered in the field. The biochemical basis for this is poorly understood and likely diverse. No stringent correlation between genetic markers and antimony resistance has so far been shown, prompting us to use a functional cloning approach to identify markers of resistance. Using gene libraries derived from drug-resistant and drug-sensitive Leishmania braziliensis clinical isolates in a functional cloning strategy, we repeatedly selected one gene locus located on chromosome 20 whose amplification confers increased antimony (III) resistance in vitro to an otherwise sensitive L. braziliensis clone. The gene responsible for the effect encodes a previously hypothetical protein that we dubbed LbrARM58. It comprises four repeats of a domain of unknown function, DUF1935, one of them harbouring a potential trans-membrane domain. The gene is so far unique to the Leishmania genus, while a structurally related gene without antimony resistance functionality is also found in Trypanosoma spp. Overexpression of LbrARM58 also confers antimony resistance to promastigotes and intracellular amastigotes of the related species Leishmania infantum, indicating a conserved function in Old World and New World Leishmania species. Our results also show that in spite of their RNAi system, L. braziliensis promastigotes can serve as acceptor cells for episomally propagated cosmid libraries, at least for the initial stages of functional cloning efforts.
Keywords: Antimony; Leishmania braziliensis; Resistance.
Figures





References
-
- Adaui V., Castillo D., Zimic M., Gutierrez A., Decuypere S., Vanaerschot M., De Doncker S., Schnorbusch K., Maes I., Van der Auwera G., Maes L., Llanos-Cuentas A., Arevalo J., Dujardin J.C. Comparative gene expression analysis throughout the life cycle of Leishmania braziliensis: diversity of expression profiles among clinical isolates. PLoS Negl. Trop. Dis. 2011;5:e1021. - PMC - PubMed
-
- Adaui V., Maes I., Huyse T., Van den Broeck F., Talledo M., Kuhls K., De Doncker S., Maes L., Llanos-Cuentas A., Schonian G., Arevalo J., Dujardin J.C. Multilocus genotyping reveals a polyphyletic pattern among naturally antimony-resistant Leishmania braziliensis isolates from Peru. Infect. Genet. Evol. 2011;11:1873–1880. - PubMed
-
- Adaui V., Schnorbusch K., Zimic M., Gutierrez A., Decuypere S., Vanaerschot M., DE Doncker S., Maes I., Llanos-Cuentas A., Chappuis F., Arevalo J., Dujardin J.C. Comparison of gene expression patterns among Leishmania braziliensis clinical isolates showing a different in vitro susceptibility to pentavalent antimony. Parasitology. 2011;138:183–193. - PubMed
-
- Arevalo J., Ramirez L., Adaui V., Zimic M., Tulliano G., Miranda-Verastegui C., Lazo M., Loayza-Muro R., De Doncker S., Maurer A., Chappuis F., Dujardin J.C., Llanos-Cuentas A. Influence of Leishmania (Viannia) species on the response to antimonial treatment in patients with American tegumentary leishmaniasis. J. Infect. Dis. 2007;195:1846–1851. - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous